SCHEMBL21695367

SCHEMBL21695367

COC(=O)Nc1csc(C)n1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GRM5 P41594 1/20 0.42
LMNA P02545 1/20 0.40
KMT2A Q03164 4/20 0.39
NPC1 O15118 3/20 0.39
RAB9A P51151 3/20 0.39
MEN1 O00255 2/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
MAPT P10636 2/20 0.39
ALOX5 P09917 1/20 0.39
PKM P14618 3/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 2/20 0.38
HPGD P15428 2/20 0.38
ALDH1A1 P00352 2/20 0.37
KDM4E B2RXH2 1/20 0.37
GAA P10253 1/20 0.37
HSD17B10 Q99714 1/20 0.37
RCE1 Q9Y256 1/20 0.37
ECE1 P42892 1/20 0.37
PIK3C3 Q8NEB9 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2600848 0.83 PI4KB (0.42) GRM5SMN1; SMN2HPGDALDH1A1
SCHEMBL21695368 0.82 GRM5 (0.45) GRM5KMT2ANPC1RAB9AMEN1
SCHEMBL22793354 0.82 GRM5 (0.38) GRM5KMT2ANPC1RAB9AMEN1
SCHEMBL20718417 0.82 GRM5 (0.38) GRM5KMT2ANPC1RAB9AMEN1
SCHEMBL2642653 0.81 GRM5 (0.44) GRM5LMNAKMT2ANPC1RAB9A
SCHEMBL9830946 0.78 KMT2A (0.41) GRM5KMT2ANPC1RAB9AL3MBTL1
SCHEMBL18236169 0.78 GRM5 (0.42) GRM5NPC1RAB9ASMN1; SMN2ALDH1A1
SCHEMBL22550476 0.77 KMT2A (0.40) GRM5KMT2ANPC1RAB9AMEN1
SCHEMBL22550401 0.77 KMT2A (0.40) GRM5KMT2ANPC1RAB9AMEN1
SCHEMBL22550537 0.77 KMT2A (0.40) GRM5KMT2ANPC1RAB9AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10556889-B1 Salvinorin derivatives Blue Sky Pharmaceuticals, LLC (US) 2020-02-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10556889-B1 Salvinorin derivatives OPRD1, OPRK1, OPRL1 GRM5 473/4885LMNA 3012/4885KMT2A 3351/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.